Heart transplantation in patients with dystrophinopathic cardiomyopathy: review of the literature and personal series

AA Papa, P D'Ambrosio, R Petillo… - Intractable & rare …, 2017 - jstage.jst.go.jp
Cardiomyopathy associated with dystrophinopathies [Duchenne muscular dystrophy (DMD),
Becker muscular dystrophy (BMD), X-linked dilated cardiomyopathy (XL-dCM) and …

ACE inhibition to slow progression of myocardial fibrosis in muscular dystrophies

V Russo, AA Papa, EA Williams, A Rago… - Trends in …, 2018 - Elsevier
Muscular dystrophy (MD) connotes a heterogeneous group of inherited disordersaffecting
skeletal and cardiac muscle. Inseveral forms of MD, the cardiac disease may be the …

[HTML][HTML] Is Cardiac Transplantation Still a Contraindication in Patients with Muscular Dystrophy-Related End-Stage Dilated Cardiomyopathy? A Systematic Review

L Politano - International Journal of Molecular Sciences, 2024 - mdpi.com
Inherited muscular diseases (MDs) are genetic degenerative disorders typically caused by
mutations in a single gene that affect striated muscle and result in progressive weakness …

[HTML][HTML] Management of cardiac involvement in muscular dystrophies: paediatric versus adult forms

A Palladino, P D'Ambrosio, AA Papa, R Petillo… - Acta …, 2016 - ncbi.nlm.nih.gov
Muscular dystrophies are a group of genetic disorders characterized by muscle
degeneration and consequent substitution by fat and fibrous tissue. Cardiac involvement is …

238th ENMC international workshop: Updating management recommendations of cardiac dystrophinopathyHoofddorp, The Netherlands, 30 november-2 december …

JP Bourke, M Guglieri, D Duboc, A Aartsma-Rus… - Neuromuscular …, 2019 - Elsevier
Twenty four neuromuscular experts, cardiologists, patient representatives and a trainee,
supported by the ENMC Young Scientist Programme, from seven European countries …

[HTML][HTML] Integrated care of muscular dystrophies in Italy. Part 1. Pharmacological treatment and rehabilitative interventions

L Politano, M Scutifero, M Patalano, A Sagliocchi… - Acta …, 2017 - ncbi.nlm.nih.gov
Integrated care of muscular dystrophies in Italy. Part 1. Pharmacological treatment and
rehabilitative interventions - PMC Back to Top Skip to main content NIH NLM Logo Access keys …

[HTML][HTML] Emergencies cards for neuromuscular disorders 1st Consensus Meeting from UILDM–Italian Muscular Dystrophy Association Workshop report

F Racca, VA Sansone, F Ricci, M Filosto… - Acta …, 2022 - ncbi.nlm.nih.gov
Acute hospitalisation may be required to support patients with Neuromuscular disorders
(NMDs) mainly experiencing respiratory complications, swallowing difficulties, heart failure …

[HTML][HTML] Beneficial effects of one-month sacubitril/valsartan treatment in a patient affected by end-stage dystrophinopathic cardiomyopathy

AA Papa, E Gallinoro, A Palladino, P Golino - Acta Myologica, 2020 - ncbi.nlm.nih.gov
Dystrophinopathic cardiomyopathy (DCM) is an almost constant manifestation in Becker
muscular dystrophy (BMD) patients significantly contributing to morbidity and mortality. The …

[PDF][PDF] Received: October 26, 2022 Accepted: December 20, 2022

F Racca, F Ricci - ACTA MYOLOGICA, 2022 - iris.unito.it
Neuromuscular disorders (NMDs) are a heterogeneous group of diseases affecting the
function of motor neurons, peripheral nerve, neuromuscular junction, or skeletal muscles …

[HTML][HTML] Giovanni Nigro and the Naples's school: historical contribution to the knowledge of heart involvement in Duchenne/Becker muscular dystrophies

L Politano - Acta Myologica, 2020 - ncbi.nlm.nih.gov
It is now accepted worldwide that cardiac involvement in Duchenne and Becker muscular
Dystrophies, is a constant feature. The concurrent impairment of the heart as a muscle in …